Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases

Laryngoscope

Volumn 114, Issue 12, 2004, Pages 2243-2248

  Xie, Minqiang ^a   Sun, Yanan ^a   Li, Yun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Lymph node metastases; Matrix metalloproteinases; Supraglottic carcinoma

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN 2;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER PATIENT; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; MATHEMATICAL MODEL; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NECK DISSECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; UPREGULATION;

ADULT; AGED; BASE SEQUENCE; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 10044271232     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000149467.18822.59     Document Type: Article

References (13)

1. Tomik J, Skladzien J, Modrzejewski M. Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx. Auris Nasus Larynx 2001;28:233-240.
2. Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-166.
3. Konttinen YT, Ainola M, Valleala H, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-697.
4. Myers EN, Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope 1996;106:559-567.
5. van den Brekel MW, van der Waal I, Meijer CJ, et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996;106:987-991.
6. Petrovic Z, Krejovic B, Janosevic S. Occult metastases from supraglottic laryngeal carcinoma. Clin Otolaryngol 1997;22:522-524.
7. Esposito ED, Motta S, Cassiano B, et al. Occult lymph node metastases in supraglottic cancers of the larynx. Otolaryngol Head Neck Surg 2001;124:253-257.
8. Ranuncolo SM, Matos E, Loria D, et al. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Cancer 2002;94:1483-1491.
9. Cazorla M, Hernandez L, Nadal A, et al. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 1998;186:144-150.
10. Sarioglu S, Ozer E, Kirimca F, et al. Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol Res Pract 2001;197:483-486.
11. Danilewicz M, Sikorska B, Wagrowska-Danilewicz M. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer. Med Sci Monit 2003;9:MT42-MT47.
12. O-charoenrat P, Rhys-Evans PH, Eccles SA, et al. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127:813-820.
13. Nishizuka I, Ichikawa Y, Ishikawa T, et al. Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo. Cancer Lett 2001;173:175-182.